GENEVA, Sept. 24 -- LA JOLLA INSTITUTE FOR IMMUNOLOGY filed a patent application (US2026/020242) for “MEASLES HEMAGGLUTININ AND FUSION MABS”. With publication no. WO/2026/198956, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: C07K 16/08
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....